All lobbying filings

GRIDIRON PUBLIC AFFAIRS, LLC

Lobbying for BEAM THERAPEUTICS · Biotech/biopharmaceutical companies

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $10,000.00 income · posted Jul 16, 2026

Official filing document

Bills named in this filing 3

HR 7871
MVP Act
HR 5187
To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing ca…
HR 7837
Most Favored Patient Act of 2026

Lobbying activity 1

Health Issues

Issues related to patient access to innovative therapies, H.R. 7871 - MVP Act, H.R. 5187 - Sickle Cell Disease, H.R. 7837 - Most Favored Nation Drug Pricing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.